Product Information

SUCRALFATE 1 GM/10 ML SUSP is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.1209 per ML under NDC 65162006205. Its NADAC has been published 340 times since Feb 19, 2020.

FDA first approved this application on Dec 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

SUCRALFATE 1 GM/10 ML SUSP

Sucralfate Oral
$0.1209per ML

Strength

1 g/10mL

NDC

65162006205

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

SUCRALFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA209356

FDA Approved

12/2/2019

TE Code

AB

On Market Since

12/2/2019

Pharmacological Classes

Aluminum Complex
Organometallic Compounds

Price Statistics

The NADAC for SUCRALFATE 1 GM/10 ML SUSP has been published 340 times since Feb 19, 2020, and over the history we have for it it has declined 71.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1209 per ML
All-time high$0.4184 (Mar 11, 2020)
All-time low$0.1153 (Jul 22, 2026)
52-week high$0.1253
52-week low$0.1153
Median price$0.3233
Average price$0.2819
Largest weekly change+53.6% (Jun 19, 2024)
Weeks tracked340
Tracking sinceFeb 19, 2020

Price History

1W

+4.9%

1M

+4.9%

3M

+2.5%

6M

-2.5%

1Y

-1.5%

3Y

-62.0%

5Y

-64.4%

All

-71.1%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of SUCRALFATE 1 GM/10 ML SUSP?

The current National Average Drug Acquisition Cost (NADAC) for SUCRALFATE 1 GM/10 ML SUSP, manufactured by Amneal Pharmaceuticals LLC, is $0.1209 per ML (NDC 65162006205), effective Aug 19, 2026.

How has the price of SUCRALFATE 1 GM/10 ML SUSP changed over time?

Over the history we have for it, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has declined 71.1%. It has been tracked across 340 weekly CMS publications since Feb 19, 2020.

What are the highest and lowest recorded NADAC prices for SUCRALFATE 1 GM/10 ML SUSP?

Since Feb 19, 2020, the NADAC for SUCRALFATE 1 GM/10 ML SUSP has ranged from a low of $0.1153 (Jul 22, 2026) to a high of $0.4184 (Mar 11, 2020), with a median of $0.3233 per ML.

Are there cheaper alternatives to SUCRALFATE 1 GM/10 ML SUSP?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SUCRALFATE 1 GM/10 ML SUSP in a comparable dosage form, but none are currently priced below it.

Who manufactures SUCRALFATE 1 GM/10 ML SUSP?

SUCRALFATE 1 GM/10 ML SUSP (NDC 65162006205) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.